Qube Research & Technologies (QRT)’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.5M | Buy |
338,163
+41,596
| +14% | +$2.03M | 0.02% | 708 |
|
|
2025
Q1 | $15.1M | Buy |
296,567
+66,436
| +29% | +$3.39M | 0.02% | 656 |
|
|
2024
Q4 | $10.4M | Buy |
230,131
+145,382
| +172% | +$6.56M | 0.01% | 815 |
|
|
2024
Q3 | $3.14M | Buy |
+84,749
| New | +$3.14M | ﹤0.01% | 1266 |
|
|
2024
Q2 | – | Sell |
-31,438
| Closed | -$915K | – | 4016 |
|
|
2024
Q1 | $915K | Buy |
+31,438
| New | +$915K | ﹤0.01% | 1864 |
|
|
2023
Q4 | – | Sell |
-10,476
| Closed | -$235K | – | 4136 |
|
|
2023
Q3 | $235K | Buy |
+10,476
| New | +$235K | ﹤0.01% | 1941 |
|
|
2022
Q4 | – | Sell |
-41,654
| Closed | -$2.09M | – | 2821 |
|
|
2022
Q3 | $2.09M | Buy |
+41,654
| New | +$2.09M | 0.01% | 870 |
|
|
2021
Q2 | – | Sell |
-13,066
| Closed | -$619K | – | 2689 |
|
|
2021
Q1 | $619K | Buy |
13,066
+4,227
| +48% | +$200K | 0.01% | 1059 |
|
|
2020
Q4 | $539K | Buy |
+8,839
| New | +$539K | 0.01% | 1082 |
|
|
2020
Q1 | – | Sell |
-6,000
| Closed | -$288K | – | 1549 |
|
|
2019
Q4 | $288K | Buy |
+6,000
| New | +$288K | 0.01% | 1239 |
|